▁British 10.375
▁Bi 10.8359375
ote 5.5859375
ch 4.51171875
' 7.37109375
s 1.03515625
▁Mar 9.0078125
im 7.9921875
ast 9.2109375
at 6.109375
▁Anti 9.21875
- 0.921875
Can 6.92578125
cer 0.783203125
▁Tre 5.8359375
at 1.82421875
ment 1.0927734375
▁to 6.10546875
▁be 4.8671875
▁Review 7.6328125
ed 0.6220703125
▁at 4.57421875
▁ES 12.09375
MO 4.0234375
▁Conference 5.640625
▁in 4.31640625
▁Vienna 5.24609375
<0x0A> 3.73046875
VI 8.5625
EN 0.09332275390625
NA 0.01027679443359375
▁- 3.529296875
▁Ex 6.52734375
c 3.41796875
itement 1.3408203125
▁is 1.0712890625
▁building 0.5390625
▁ahead 1.828125
▁of 0.0084075927734375
▁this 2.4140625
▁year 0.77001953125
' 0.006534576416015625
s 0.00044798851013183594
▁European 1.6044921875
▁Society 0.1802978515625
▁for 1.248046875
▁Medical 0.11407470703125
▁On 0.060882568359375
col 0.0002675056457519531
ogy 3.814697265625e-06
▁( 0.2462158203125
ES 0.007106781005859375
MO 0.00015532970428466797
) 0.02239990234375
▁conference 3.33984375
▁in 1.6328125
▁Vienna 0.05096435546875
, 0.67041015625
▁as 3.22265625
▁British 8.28125
▁bi 4.71484375
ote 0.1741943359375
ch 0.1673583984375
▁company 1.4443359375
, 2.435546875
▁Bi 5.203125
ote 1.3349609375
ch 0.6611328125
Co 7.04296875
, 0.5400390625
▁prepar 2.224609375
es 0.0008182525634765625
▁to 0.232177734375
▁present 2.673828125
▁its 1.0361328125
▁ground 2.890625
bre 1.2578125
aking 0.00010478496551513672
▁anti 3.7578125
- 0.00945281982421875
can 0.242919921875
cer 0.0005426406860351562
▁treatment 1.1796875
, 1.15234375
▁Mar 5.79296875
im 1.6259765625
ast 0.493408203125
at 0.002086639404296875
. 1.7216796875
▁Exper 8.8046875
ts 0.07763671875
▁are 2.390625
▁eager 2.48046875
ly 0.6376953125
▁await 1.119140625
ing 0.004138946533203125
▁the 0.53466796875
▁review 7.5
▁of 0.340087890625
▁the 0.9375
▁drug 3.48828125
, 1.5302734375
▁which 0.5380859375
▁shows 4.4453125
▁promise 1.1181640625
▁for 1.8466796875
▁revolution 8.2578125
izing 1.5576171875
▁cancer 1.7177734375
▁treatment 0.465576171875
. 0.85302734375
<0x0A> 0.36572265625
Mar 1.3251953125
im 0.0030307769775390625
ast 0.004199981689453125
at 0.001068115234375
, 1.71875
▁an 3.1015625
▁or 1.9169921875
al 0.27734375
▁medic 3.271484375
ation 0.016143798828125
, 0.9697265625
▁has 1.9140625
▁been 1.0322265625
▁ha 5.046875
iled 0.00042629241943359375
▁as 0.4033203125
▁a 0.64013671875
▁potential 1.9150390625
▁game 1.11328125
- 0.4892578125
ch 0.00321197509765625
anger 0.08050537109375
▁in 0.7568359375
▁the 0.55810546875
▁battle 2.505859375
▁against 0.0699462890625
▁cancer 0.364990234375
. 0.67236328125
▁It 2.01953125
▁targets 3.173828125
▁the 1.62109375
▁matrix 9.4765625
▁metal 0.0877685546875
lo 0.002803802490234375
prote 0.0194549560546875
in 0.1121826171875
ase 0.260498046875
▁en 3.59765625
zym 0.00170135498046875
es 1.8974609375
▁involved 4.390625
▁in 0.016571044921875
▁the 0.97119140625
▁spread 4.18359375
▁and 2.02734375
▁growth 1.1533203125
▁of 0.005931854248046875
▁cancer 0.82958984375
▁cells 0.487548828125
. 0.60986328125
▁The 2.0703125
▁drug 1.341796875
' 3.58984375
s 0.0004763603210449219
▁ability 2.82421875
▁to 0.01457977294921875
▁in 2.302734375
hib 0.03436279296875
it 0.0021877288818359375
▁these 1.0625
▁en 0.33251953125
zym 0.0001933574676513672
es 0.0058441162109375
▁has 1.7060546875
▁shown 3.376953125
▁significant 3.07421875
▁potential 2.87109375
▁in 0.7265625
▁slow 4.1640625
ing 0.0004475116729736328
▁or 2.083984375
▁even 1.4208984375
▁hal 0.98779296875
ting 0.0017633438110351562
▁cancer 1.7607421875
▁pro 1.4296875
gression 0.0176544189453125
▁in 1.31640625
▁pre 2.337890625
cl 0.72021484375
in 3.1828880310058594e-05
ical 0.0009093284606933594
▁tri 1.2392578125
als 0.00016641616821289062
. 0.3759765625
▁E 8.0
ager 2.880859375
▁to 0.50732421875
▁un 5.16015625
ve 0.580078125
il 0.00038623809814453125
▁their 2.513671875
▁find 2.35546875
ings 0.0012388229370117188
, 0.64013671875
▁Bi 1.18359375
ote 0.0012083053588867188
ch 0.006496429443359375
Co 0.0157928466796875
▁secured 6.9375
▁a 1.2392578125
▁pr 3.751953125
estig 0.001678466796875
ious 0.00045752525329589844
▁slot 4.5546875
▁at 0.513671875
▁the 1.1474609375
▁ES 0.72802734375
MO 0.0012083053588867188
▁conference 0.498291015625
, 1.185546875
▁which 1.845703125
▁attract 3.357421875
s 0.046844482421875
▁leading 3.154296875
▁on 1.890625
colog 1.236328125
ists 0.0242919921875
▁and 1.2109375
▁medical 2.8984375
▁profession 1.53125
als 0.00027298927307128906
▁from 0.1993408203125
▁around 0.5283203125
▁the 0.004486083984375
▁world 0.1722412109375
. 0.1619873046875
<0x0A> 0.248779296875
Dr 3.46875
. 0.560546875
▁Em 6.2734375
ily 1.4931640625
▁Anderson 6.125
, 0.1549072265625
▁lead 3.783203125
▁research 1.7470703125
er 0.0247802734375
▁at 1.8583984375
▁Bi 0.51220703125
ote 0.0006928443908691406
ch 0.0049591064453125
Co 0.01329803466796875
, 0.345703125
▁expressed 5.1328125
▁enthus 3.869140625
ias 0.0064849853515625
m 0.00017023086547851562
▁about 1.810546875
▁the 0.26318359375
▁up 2.7109375
coming 0.00441741943359375
▁presentation 1.8447265625
. 0.953125
▁Spe 6.12109375
aking 0.002796173095703125
▁at 2.197265625
▁the 0.640625
▁company 3.708984375
' 0.0302734375
s 0.00022530555725097656
▁headquarters 3.359375
▁in 0.275634765625
▁London 2.14453125
, 0.102783203125
▁she 0.841796875
▁said 0.65576171875
, 0.77880859375
▁" 0.06292724609375
Mar 2.697265625
im 0.00046443939208984375
ast 0.0021228790283203125
at 0.0006775856018066406
▁has 1.283203125
▁the 0.92236328125
▁potential 0.10064697265625
▁to 0.01494598388671875
▁transform 2.482421875
▁the 0.96337890625
▁way 1.0107421875
▁we 1.041015625
▁approach 2.8671875
▁cancer 0.3369140625
▁treatment 0.7060546875
. 0.65283203125
▁Initial 8.265625
▁tests 4.4140625
▁have 0.8134765625
▁shown 0.332275390625
▁incred 4.09765625
ibly 2.75390625
▁prom 0.763671875
ising 4.470348358154297e-05
▁results 0.09906005859375
, 0.7080078125
▁and 0.53173828125
▁we 0.60693359375
▁are 1.2080078125
▁eager 1.4384765625
▁to 0.1417236328125
▁share 1.0498046875
▁our 0.849609375
▁find 0.78173828125
ings 2.0503997802734375e-05
▁with 0.5556640625
▁the 0.446533203125
▁medical 1.31640625
▁community 0.27880859375
▁at 1.6455078125
▁ES 0.98388671875
MO 0.00044846534729003906
." 0.53173828125
<0x0A> 0.0728759765625
The 1.9921875
▁significance 7.98828125
▁of 0.02264404296875
▁this 2.24609375
▁review 5.5078125
▁lies 3.662109375
▁in 0.135498046875
▁Mar 3.87890625
im 0.0008764266967773438
ast 0.0028095245361328125
at 0.0017528533935546875
' 0.031036376953125
s 0.0003561973571777344
▁potential 2.025390625
▁as 2.615234375
▁a 0.265625
▁novel 3.720703125
▁th 3.083984375
era 0.0001226663589477539
pe 4.2319297790527344e-05
ut 6.580352783203125e-05
ic 0.0044708251953125
▁option 1.607421875
▁for 0.62744140625
▁a 2.69921875
▁wide 1.2509765625
▁range 0.271240234375
▁of 0.0014238357543945312
▁can 0.55029296875
cers 6.091594696044922e-05
. 0.473388671875
▁Trad 5.171875
itionally 1.4208984375
, 0.064453125
▁cancer 1.392578125
▁treat 1.775390625
ments 0.0001264810562133789
▁have 0.59375
▁focused 1.044921875
▁on 0.07989501953125
▁surg 4.79296875
ery 0.18603515625
, 0.20751953125
▁radiation 1.029296875
▁ther 1.6318359375
apy 0.01418304443359375
, 0.25732421875
▁and 0.51611328125
▁chem 0.1888427734375
other 0.01506805419921875
apy 0.01187896728515625
. 0.71728515625
▁While 3.181640625
▁effective 2.544921875
, 0.29296875
▁these 0.2568359375
▁methods 2.80859375
▁often 2.3984375
▁come 2.90625
▁with 0.1488037109375
▁severe 2.994140625
▁side 0.145263671875
▁effects 0.10260009765625
▁and 1.2958984375
▁limited 2.958984375
▁success 1.58203125
▁rates 1.1767578125
, 2.783203125
▁particularly 2.46875
▁in 0.5751953125
▁advanced 3.125
▁stages 2.390625
▁of 0.26220703125
▁the 1.15234375
▁disease 0.07830810546875
. 0.042266845703125
▁Mar 1.53515625
im 0.00027751922607421875
ast 0.001308441162109375
at 0.0003407001495361328
' 2.34765625
s 4.1484832763671875e-05
▁unique 2.763671875
▁mechanism 2.103515625
▁of 0.139892578125
▁action 0.01520538330078125
▁offers 2.744140625
▁hope 2.783203125
▁for 0.364501953125
▁more 3.025390625
▁target 1.9609375
ed 0.00274658203125
▁and 1.3310546875
▁less 2.7265625
▁invas 1.650390625
ive 6.842613220214844e-05
▁treat 1.2353515625
ments 4.744529724121094e-05
. 0.85888671875
<0x0A> 0.3720703125
ES 4.54296875
MO 0.0025959014892578125
▁conference 3.685546875
▁at 0.99365234375
ten 2.944469451904297e-05
de 1.2516975402832031e-05
es 0.0165863037109375
▁are 1.4013671875
▁eager 0.5537109375
ly 1.2138671875
▁anticip 1.048828125
ating 0.003154754638671875
▁the 0.496826171875
▁session 7.91015625
▁led 7.7109375
▁by 0.0016069412231445312
▁Bi 1.248046875
ote 0.0003693103790283203
ch 0.00405120849609375
Co 0.00839996337890625
' 1.19921875
s 0.000171661376953125
▁team 2.970703125
. 1.3935546875
▁The 1.765625
▁event 4.09375
▁is 1.6083984375
▁known 7.3359375
▁for 0.54296875
▁show 2.712890625
c 0.0022373199462890625
asing 6.35385513305664e-05
▁break 3.427734375
through 0.002582550048828125
▁develop 4.28515625
ments 2.0742416381835938e-05
▁in 0.2169189453125
▁on 1.541015625
col 0.013916015625
ogy 4.3511390686035156e-05
▁and 1.97265625
▁fost 7.08984375
ering 0.042724609375
▁collaboration 2.1484375
▁between 0.44287109375
▁research 1.6181640625
ers 0.040313720703125
▁and 0.52587890625
▁industry 1.5234375
▁profession 2.232421875
als 2.5153160095214844e-05
. 0.11334228515625
▁With 2.62890625
▁over 3.21484375
▁ 0.057403564453125
3 2.087890625
0 1.5
, 1.1103515625
0 0.001708984375
0 1.3828277587890625e-05
0 0.0027751922607421875
▁participants 2.01171875
▁expected 2.017578125
▁to 1.3466796875
▁attend 0.09405517578125
, 0.533203125
▁there 4.5703125
▁will 1.8173828125
▁be 0.0853271484375
▁am 1.61328125
ple 0.0006299018859863281
▁opportunity 0.134521484375
▁for 0.487060546875
▁scientific 6.01171875
▁exchange 1.755859375
▁and 0.60791015625
▁networking 1.435546875
. 0.1700439453125
<0x0A> 0.452880859375
However 7.0625
, 0.0050811767578125
▁some 5.0703125
▁exper 1.5693359375
ts 4.291534423828125e-06
▁are 0.7666015625
▁ur 6.4765625
ging 0.0025691986083984375
▁ca 0.016876220703125
ution 6.306171417236328e-05
▁until 7.25
▁the 1.20703125
▁drug 1.43359375
' 2.0859375
s 0.0001614093780517578
▁effic 1.978515625
acy 1.1801719665527344e-05
▁and 1.904296875
▁safety 0.231201171875
▁have 0.76220703125
▁been 0.0030193328857421875
▁thoroughly 1.8076171875
▁tested 1.4267578125
▁in 1.0009765625
▁human 2.73046875
▁tri 0.56787109375
als 5.0067901611328125e-06
. 0.0155487060546875
▁Dr 2.12890625
. 0.01203155517578125
▁Sarah 5.703125
▁Mitchell 7.03125
▁from 3.58203125
▁Vienna 12.0
▁General 5.08984375
▁Hospital 0.06060791015625
▁bel 3.3125
ieves 0.0005116462707519531
▁that 0.5986328125
▁while 3.818359375
▁Mar 1.099609375
im 0.0006556510925292969
ast 0.0023746490478515625
at 0.00055694580078125
' 2.14453125
s 0.00023984909057617188
▁pre 5.6171875
cl 0.69677734375
in 2.5272369384765625e-05
ical 0.0008153915405273438
▁results 1.310546875
▁are 0.182373046875
▁impress 2.982421875
ive 0.0007801055908203125
, 0.011077880859375
▁further 2.439453125
▁research 1.5537109375
▁is 0.18701171875
▁needed 0.59375
▁to 0.66015625
▁fully 3.126953125
▁understand 0.90234375
▁its 0.260009765625
▁potential 0.424560546875
▁benefits 2.193359375
▁and 2.09375
▁draw 1.80078125
back 0.00027680397033691406
s 0.00027823448181152344
. 0.084716796875
▁" 1.376953125
It 2.205078125
▁is 1.40234375
▁essential 3.314453125
▁that 0.7236328125
▁we 1.494140625
▁approach 8.1015625
▁this 1.36328125
▁new 2.39453125
▁treatment 0.6572265625
▁option 4.4453125
▁with 0.1702880859375
▁an 3.859375
▁open 0.049591064453125
▁mind 0.01800537109375
▁but 7.9453125
▁remain 4.12109375
▁w 4.328125
ary 4.780292510986328e-05
▁of 0.26416015625
▁any 2.009765625
▁un 1.8427734375
for 1.9638671875
ese 0.00371551513671875
en 0.00789642333984375
▁comp 3.029296875
lications 0.0015125274658203125
," 0.521484375
▁she 0.2257080078125
▁ad 6.1328125
vised 0.006061553955078125
. 0.03582763671875
<0x0A> 0.315673828125
As 3.849609375
▁the 0.81396484375
▁ES 4.5625
MO 0.0013980865478515625
▁conference 0.08197021484375
▁approaches 2.01953125
, 0.01953125
▁anticip 6.0703125
ation 0.0146331787109375
▁is 0.546875
▁building 1.4638671875
▁in 3.802734375
▁the 0.28857421875
▁medical 1.7626953125
▁community 0.10833740234375
. 0.8193359375
▁Bi 1.212890625
ote 0.0004124641418457031
ch 0.01378631591796875
Co 0.01580810546875
' 0.84326171875
s 0.00024211406707763672
▁presentation 1.685546875
▁on 3.173828125
▁Mar 0.1729736328125
im 0.00015425682067871094
ast 0.0013751983642578125
at 0.00015175342559814453
▁is 0.58349609375
▁expected 1.306640625
▁to 0.0003974437713623047
▁be 0.67236328125
▁one 2.015625
▁of 0.028411865234375
▁the 0.0229949951171875
▁highlight 2.271484375
s 0.0016412734985351562
▁of 0.361083984375
▁the 0.1024169921875
▁event 0.487548828125
, 0.90234375
▁spark 7.87109375
ing 0.00037217140197753906
▁discuss 3.501953125
ions 1.4185905456542969e-05
, 5.43359375
▁collabor 5.05078125
ations 0.020355224609375
, 0.0950927734375
▁and 0.004550933837890625
▁potential 2.509765625
▁adv 2.986328125
anc 0.291748046875
ements 1.5616416931152344e-05
▁in 0.1412353515625
▁cancer 0.66162109375
▁treatment 0.278076171875
. 0.0638427734375
▁The 2.88671875
▁outcome 5.49609375
▁of 0.1494140625
▁this 0.76513671875
▁review 1.140625
▁has 4.25
▁the 0.047760009765625
▁potential 0.045257568359375
▁to 0.004604339599609375
▁shape 2.609375
▁the 0.165771484375
▁future 0.2900390625
▁of 0.0199127197265625
▁cancer 1.43359375
▁th 7.3828125
era 0.0003046989440917969
pe 1.823902130126953e-05
ut 1.1682510375976562e-05
ics 0.0029048919677734375
, 0.92919921875
▁deliver 7.0234375
ing 0.00449371337890625
▁hope 1.6689453125
▁to 0.55908203125
▁millions 2.7109375
▁world 3.6640625
wide 0.00047707557678222656
. 0.09521484375
